---
title: "SC Pharmaceuticals fell over 6% and again warned of potential *ST status"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229698783.md"
description: "SC Pharmaceuticals fell over 6% to HKD 14.6, with a total market value of HKD 6.18 billion. The company announced after the market closed yesterday that, according to preliminary calculations by the finance department, it expects a net profit attributable to shareholders of the listed company to be negative for the fiscal year 2024, and the operating revenue after deductions to be below HKD 300 million. According to the relevant provisions of the Shenzhen Stock Exchange's listing rules, the company's stock trading may be subject to delisting risk warnings after the disclosure of the 2024 annual report. This is the second risk warning regarding the potential delisting risk for the company's stock trading"
datetime: "2025-02-26T06:25:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229698783.md)
  - [en](https://longbridge.com/en/news/229698783.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229698783.md)
generator: "portal-rs"
---

# SC Pharmaceuticals fell over 6% and again warned of potential *ST status

SC Pharmaceuticals fell over 6% to HKD 14.6, with a total market value of HKD 6.18 billion. The company announced after the market closed yesterday that, according to preliminary calculations by the finance department, it expects a net profit attributable to shareholders of the listed company to be negative for the fiscal year 2024, and the operating revenue after deductions to be below HKD 300 million. In accordance with the relevant provisions of the Shenzhen Stock Exchange's listing rules, the company's stock trading may be subject to delisting risk warnings after the disclosure of the 2024 annual report. This is the second risk warning regarding the potential delisting risk for the company's stock trading

### Related Stocks

- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)

## Related News & Research

- [Trump 'happy' Harry and Meghan left the United States: 'I was not a fan'](https://longbridge.com/en/news/297821241.md)
- [Nutra Pharma says Pure Raw Supplies gains control with 62.63% voting power after Series B transfer](https://longbridge.com/en/news/297819211.md)
- [OpenAI's new model "Astra": Core technology enables super-powerful inference.](https://longbridge.com/en/news/297863964.md)
- [12:46 ETLeopard Imaging Introduces DragonFire High-Performance Uncooled Infrared Camera Module for Industrial Thermal Imaging](https://longbridge.com/en/news/297813035.md)
- [Nutra Pharma files Form 3 as Pure Raw Supplies reports 12 million Series B preferred shares](https://longbridge.com/en/news/297690871.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**